FDA Investigator Kelsey M Bishop
Kelsey M Bishop has conducted inspections on 93 sites in 1 countries as of 21 Sep 2017. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
93
Last Inspection Date:
21 Sep 2017
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kelsey M Bishop:
Aaron J Poloni,
Alexander M Kay,
Alicia Aborg Borm,
Alicia M Weitzel,
Anita Narula, PhD,
Annette L Diggs,
Arie R Dyk,
Ashleigh P Barkans,
Avery J Dennis,
Barbara J Rincon,
Beau R Lamb,
Bruce R Burrell,
Carol A Gripp,
Ce'nedra M Martin,
Celia L Hutchinstein,
Clint R Van Blaricom,
Connie P Rezendes,
Crystal A Harlan,
Cynthia J Lee, MS,
Cynthia L Gorveatt,
Dandan Wang, PhD,
Dawn E Barkans,
Devon M Shoop,
Dirk L Lincoln,
Don A Brunssen,
Donald B Mckechnie,
Douglas J Scott,
Elizabeth S Howell,
Emal Wahab,
Farhana Khan,
Gerard Pde Leon,
Gloria J Baca, MS,
Gordon T Wales,
Hanna L Potter,
Hugh A Grimoldby,
Hughes,
Ian J Thomson,
Isaiah D Isakson,
James D Hildreth,
James S Stuart, BS,
Jean C Colon Lopez,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jessica B Clark,
John A Hall,
John E Emmert,
Julia Ventura,
Julian C Hanson,
Katharine Chan,
Katherine L Arnold,
Katherine L Ernest,
Kathryn A Krentz,
Keegan B Mixon,
Kimberly Jproctor Jones,
Kurt M Hafer,
Lance W Bohm,
Leon R Marquart,
Lisa A Bowden,
Lisa K Capron,
Lori J Jennings,
Marcus A Goshen,
Margo C Jones,
Mark S Crippen,
Michael J Lackey,
Michael S Hudson,
Michael S Valenzuela,
Mikel T Wright,
Nancy A Saxenian Emmons,
Nancy E Byerly,
Nancy E Doyle,
Neil J Traaen,
Ngoc Lan T Nguyen,
Paul F Rader,
Paul M Kawamoto,
Peter T Regan,
Philippe A Cornet,
Rachelle M Deskins,
Robert A Williams,
Robert F Hennes,
Robert J Vezzetti,
Sangeeta M Khurana, PhD,
Scott A Nabe,
Shannon J Hall,
Sonia R Peterson,
Stacy A Schneider,
Stephanie A Jameson,
Sunitha K Rajaram, PhD,
Tara M Pianko,
Thomas C Mclean, CFS,
Tracy K Li,
William C Hughes,
Zachary L Miller
Kelsey M Bishop's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2013 | EIR | George S. Allen, MD - EIR, 2013-05-03 |
August, 2013 | EIR | Himmelspach, William W. - EIR, 2013-08-30 |
May, 2013 | FDA 483 | George S. Allen, MD - Form 483, 2013-05-03 |
March, 2014 | FDA 483 | Independent Nutrition, Inc. - Form 483, 2014-03-21 |
October, 2012 | EIR | Mountain Vista Dairy - EIR, 2012-10-18 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more